UNIGE document Scientific Article
previous document  unige:89945  next document
add to browser collection

Update on multiple sclerosis treatments

Published in Swiss Medical Weekly. 2014, vol. 144, w14012
Abstract Relapsing-remitting multiple sclerosis (RRMS) management has dramatically changed over the past decade. New drugs have arrived on the market, allowing for more individualised treatment selection. However, this diversity has increased the complexity of RRMS patient follow-up. In this review, we provide summarised information about treatment efficacy, potential side-effects, follow-up recommendations, vaccinations, and pregnancy safety issues for all currently available disease modifying therapies and those awaiting approval.
Keywords Antibodies, Monoclonal, Humanized/therapeutic useCrotonates/therapeutic useDimethyl FumarateFingolimod HydrochlorideFumarates/therapeutic useHumansImmunoglobulin G/therapeutic useImmunosuppressive Agents/administration & dosage/adverse effects/therapeutic useInterferon-beta/therapeutic useMultiple Sclerosis, Relapsing-Remitting/drug therapyNatalizumabPropylene Glycols/therapeutic useSphingosine/analogs & derivatives/therapeutic useToluidines/therapeutic use
PMID: 25247669
Full text
Article (Published version) (436 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research group Scléroses en plaques, neuroimmunologie, encéphalite autoimmune expérimentale (843)
(ISO format)
BRIDEL, Claire, LALIVE D'EPINAY, Patrice. Update on multiple sclerosis treatments. In: Swiss Medical Weekly, 2014, vol. 144, p. w14012. doi: 10.4414/smw.2014.14012 https://archive-ouverte.unige.ch/unige:89945

317 hits

0 download


Deposited on : 2016-12-07

Export document
Format :
Citation style :